Joe attends and presents at a fantastic meeting on Pancreatic Cancer organized in part by Dr. Brian Wolpin of DFCI. Joe presents on initial work from the lab investigating how to use mass spectrometry-based quantitative proteomics to identify adaptations to oncogenic KRAS inhibition.
0 Comments
Leave a Reply. |
Archives
September 2022
Categories |